Drug profile

The FDA adverse-event record for Glucosamine Hcl (Shellfish), Methylsulfonylmethane (Msm), Creatine Monohydrate, Boswellia Serrata Extract

23 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Glucosamine Hcl (Shellfish), Methylsulfonylmethane (Msm), Creatine Monohydrate, Boswellia Serrata Extract. See the species affected, top reactions, and outcomes below.

23
adverse-event reports
21.7%
death-coded share
Dog
most-reported species
7
Diarrhoea - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
23
Total Reports
5
Deaths Reported
21.7%
Death Rate

Active Ingredients

Glucosamine Hcl (Shellfish), Methylsulfonylmethane (Msm), Creatine Monohydrate, Boswellia Serrata Extract

Administration Routes

OralUnknown

Species Affected

Dog 23

Most Affected Breeds

Sheepdog - Shetland 5
Retriever - Labrador 5
Retriever - Golden 2
Dog (unknown) 2
Bichon Frise 1
Crossbred Canine/dog 1
Munsterlander - Large 1
Terrier - West Highland White 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Terrier - Yorkshire 1

Most Reported Reactions

Diarrhoea 7
Behavioural disorder NOS 6
Death 5
Abnormal stool colouration 5
Loose stool 5
Flatulence 5
Restlessness 5
Vomiting 4
Vocalisation 4
Musculoskeletal disorder NOS 4
Lack of efficacy (endoparasite) - roundworm NOS 4
Skin lesion NOS 4

Outcome Breakdown

Outcome Unknown
7 (30.4%)
Ongoing
6 (26.1%)
Died
5 (21.7%)
Recovered/Normal
5 (21.7%)

Glucosamine Hcl (Shellfish), Methylsulfonylmethane (Msm), Creatine Monohydrate, Boswellia Serrata Extract Adverse Event Insights

23 reports name Glucosamine Hcl (Shellfish), Methylsulfonylmethane (Msm), Creatine Monohydrate, Boswellia Serrata Extract; 5 recorded a death outcome (21.7% of reported events, not a population-level mortality rate). Active ingredient: Glucosamine Hcl (Shellfish), Methylsulfonylmethane (Msm), Creatine Monohydrate, Boswellia Serrata Extract. Administration routes: Oral, Unknown.

By species: Dog (23 reports). By breed: Sheepdog - Shetland (5), Retriever - Labrador (5), Retriever - Golden (2).

Leading clinical signs: Diarrhoea (7), Behavioural disorder NOS (6), Death (5), Abnormal stool colouration (5). Outcome, 23 coded reports: Outcome Unknown leads at 30.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.